Target Gene Table ▼
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30084011HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30085205HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30081553HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30088725HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30077661HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30086976HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30026529HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30026530HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS30026531HIVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20002422HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TCGA Plot Options ▼
Drug Information ▼
GeneESRRG
DrugBank IDDB02659
Drug NameCholic Acid
Target IDBE0002088
UniProt IDP62508
Regulation Type
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved
Direct ClassificationTrihydroxy bile acids, alcohols and derivatives
SMILES[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
PathwaysCongenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX)
PharmGKBPA166160055
ChEMBLCHEMBL205596